Capricor Therapeutics (CAPR) Announces Completion of Phase I/II HOPE-Duchenne Trial Enrollment
Go back to Capricor Therapeutics (CAPR) Announces Completion of Phase I/II HOPE-Duchenne Trial Enrollment| Capricor Therapeutics, Inc. (NASDAQ: CAPR) | Delayed: 4.82 -0.12 (2.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.94 | 52 Week High | $5.40 | |||
| Open | $4.90 | 52 Week Low | $1.88 | |||
| Day High | $5.02 | P/E | N/A | |||
| Day Low | $4.70 | EPS | $0.00 | |||
| Volume | 478,470 | |||||
